Alirocumab clinical trials PCSK9 Inhibitors

Praluent - SAR236553 - monoclonal antibody REGN727 - REGN727 monoclonal antibody - alirocumab

Recap Results Trial description old Pinterest treatment           Z

Cardiovascular prevention

All type of patients:  14 trials  - ODYSSEY OUTCOMES - ODYSSEY Long-Term - CHOICE I - CHOICE II - NCT01288469 - ODYSSEY Alternative - ODYSSEY COMBO - ODYSSEY COMBO II - ODYSSEY FH 1 - ODYSSEY FH 2 - ODYSSEY HIGH FH - ODYSSEY MONO - ODYSSEY OPTIONS I - ODYSSEY OPTIONS II




- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons